The board of directors have resolved not to distribute dividends

Announcement by the Company’s Board of Directors to convene the 2016 Annual General Shareholders’ meeting
March 9, 2017
OBI-833, the cancer therapeutic vaccine, has met the primary safety indicators in Phase I clinical trial for US and Taiwan
April 6, 2017
  1. Date of the board of directors resolution : 9 Mar 2017
  2. (1) Appropriations of earnings in cash dividends to shareholders (NT$ per share): 0
    (2) Cash distributed from legal reserve and capital surplus to shareholders (NT$ per share): 0
    (3) Total amount of cash distributed to shareholders (NT$):0
    (4) Appropriations of earnings in stock dividends to shareholders (NT$ per share): 0
    (5) Stock distributed from legal reserve and capital surplus to shareholders (NT$ per share): 0
    (6) Total amount of stock distributed to shareholders (shares): 0
  3. Any other matters that need to be specified: None